Fidia S.p.A.
FDA.MI · MIL
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €17 | €29 | €24 | €24 |
| % Growth | -38.9% | 17.4% | 2.2% | – |
| Cost of Goods Sold | €5 | €9 | €23 | €8 |
| Gross Profit | €13 | €19 | €1 | €16 |
| % Margin | 74.2% | 66.9% | 5.9% | 65.1% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €3 | €2 | €1 | €2 |
| SG&A Expenses | €3 | €2 | €1 | €2 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €17 | €18 | -€1 | €16 |
| Operating Expenses | €20 | €21 | €7 | €19 |
| Operating Income | -€7 | -€2 | -€5 | -€3 |
| % Margin | -37.6% | -5.8% | -21.8% | -12.9% |
| Other Income/Exp. Net | -€3 | €0 | €11 | -€1 |
| Pre-Tax Income | -€9 | -€1 | €6 | -€3 |
| Tax Expense | €0 | €0 | -€0 | €0 |
| Net Income | -€9 | -€1 | €6 | -€3 |
| % Margin | -53.2% | -4.6% | 24.5% | -14.7% |
| EPS | -0.27 | -0.19 | 0.86 | -0.68 |
| % Growth | -42.1% | -122.1% | 226.5% | – |
| EPS Diluted | -0.27 | -0.19 | 0.86 | -0.68 |
| Weighted Avg Shares Out | 34 | 7 | 7 | 5 |
| Weighted Avg Shares Out Dil | 34 | 7 | 7 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €1 | €0 | €0 |
| Depreciation & Amortization | €1 | €1 | €2 | €2 |
| EBITDA | -€8 | €1 | €8 | -€1 |
| % Margin | -43.8% | 2.3% | 31.3% | -3.7% |